{
}
UBS has reaffirmed its Buy rating on Valero Energy, maintaining a $160 price target despite lowering its Q1 2025 EPS estimate to $0.58, below the consensus of $1.09, due to underperformance in the refining and marketing division. The company is expected to repurchase $220 million in shares and has reported strong Q4 2024 earnings, exceeding expectations with an EPS of $0.64 and revenue of $30.76 billion. Analysts anticipate improved earnings in Q2 2025, driven by favorable supply dynamics and a focus on renewable diesel expansion.
UBS has reiterated its Buy rating for Valero Energy, maintaining a price target of $160, despite lowering Q1 2025 EPS guidance to $0.58 due to disappointing refining results. The company is expected to continue its aggressive share buyback program and improve its refining and marketing results in Q2 2025, aided by favorable supply dynamics and a focus on renewable diesel expansion. Valero's strong Q4 2024 performance, with EPS of $0.64 and revenue of $30.76 billion, underscores its financial resilience amid market fluctuations.
UBS has reiterated its Buy rating for Darling Ingredients, maintaining a price target of $58, significantly above its current price of $31.24. Despite slight downward adjustments to EBITDA forecasts for 2025 due to weaker pricing for Low Carbon Fuel Standard credits, analysts remain optimistic about the company's potential in renewable diesel and sustainable fuels. Darling reported a net income increase for Q4, although revenues fell short of expectations, reflecting strong profitability and positive future projections.
UBS analyst Manav Gupta has reaffirmed a Buy rating on Darling Ingredients (NYSE: DAR) with a price target of $58.00. The analyst's positive outlook reflects confidence in the company's performance and market position.
Darling Ingredients Inc. operates in three segments: Feed Ingredients, Food Ingredients, and Fuel Ingredients, providing customized solutions across various industries, including pharmaceuticals and bioenergy. The company has a Moderate Buy rating from analysts, with a consensus target price of $52.75. Recently, Zurcher Kantonalbank increased its stake by 17.3%, reflecting growing institutional interest, while the stock has shown a 52-week range between $27.20 and $48.39.
UBS has lowered its price target for Darling Ingredients Inc. to $58 from $63 while maintaining a Buy rating. The company specializes in developing sustainable natural ingredients from bio-nutrients, serving various industries including pharmaceuticals, food, and bioenergy through its Feed, Food, and Fuel Ingredients segments.
Darling Ingredients Inc.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs maintains buy rating on valero energy with revised earnings outlook
15:39 01.04.2025
ubs maintains buy rating for valero energy with price target of 160 dollars
15:32 01.04.2025
ubs maintains buy rating for darling ingredients with price target of 58 dollars
15:29 01.04.2025
ubs maintains buy rating and price target for darling ingredients
14:44 01.04.2025
darling ingredients reports strong earnings and sees institutional investment growth
08:43 17.03.2025
ubs lowers darling ingredients price target while maintaining buy rating
14:26 03.03.2025
Trending
Subcategory
Startups & Entrepreneurship
Corporate News
Industry Trends
Supply Chain Management
Retail and Consumer Goods
Global Trade Developments
Stock Market Updates
Private Equity Deals
Industry Mergers & Acquisitions
AI Applications
AI Innovations
Funding Rounds & Investments
Fintech Startups
Global Financial Events
Energy Sector Developments
Government Economic Policies
CEO Changes
Emerging Startups
Corporate Social Responsibility
Commodities
Countries:
Companies:
Apple Inc.
Google Inc.
Amazon.com, Inc.
OpenAI ERC USD
Tesmec S.p.A.
Tesla, Inc.
Microsoft Corporation
Wise plc
Mastercard Inc
Walmart Inc.
Mistral 1
Foxconn Technology Co., Ltd.
Nippon Steel Corp
Hollywood Bowl Group PLC
NASDAQ Composite
CCTV 50 CSR
Medtronic plc
Johnson & Johnson
GE HealthCare Technologies Inc.
McDonald's Corporation
Currencies:
United States Dollar
Indian Rupee
Chinese Yuan
Euro
British Pound Sterling
United Arab Emirates Dirham
Japanese Yen
New Zealand Dollar
Thai Baht
Vietnamese Đồng
Australian Dollar
Singapore Dollar
Saudi Riyal
Omani Rial
Bahraini Dinar
Qatari Riyal
Algerian Dinar
People: